Dr James N Sikes, MD, | |
3688 Veterans Memorial Dr, Suite 200, Hattiesburg, MS 39401-8246 | |
(601) 554-7400 | |
(601) 554-7488 |
Full Name | Dr James N Sikes |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 31 Years |
Location | 3688 Veterans Memorial Dr, Hattiesburg, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225067127 | NPI | - | NPPES |
0119853 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 13940 (Mississippi) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Forrest General Home Care | Hattiesburg, MS | Home health agency |
St Luke Home Health Services | Mccomb, MS | Home health agency |
Forrest General Hospital | Hattiesburg, MS | Hospital |
South Central Reg Med Ctr | Laurel, MS | Hospital |
King's Daughters Medical Center-brookhaven | Brookhaven, MS | Hospital |
Merit Health Wesley | Hattiesburg, MS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Southern Bone And Joint Specialists Pa | 1254328818 | 43 |
News Archive
Pairing chemotherapy nanodrugs with a nutritional supplement can lessen devastating side-effects while reducing the amount of the expensive drugs needed to treat cancer according to a study from Carnegie Mellon University and Taiwan's National Health Research Institutes.
The Northern Devon Healthcare Trust (NDHT) is using a speech recognition solution, from voice automation specialist Telephonetics VIP, to answer external calls at busy times.
Omeros Corporation today announced that patient enrollment has begun in the Company's second Phase 3 clinical trial evaluating OMS302 in intraocular lens replacement (ILR) surgery.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
› Verified 6 days ago
Entity Name | Southern Bone & Joint Specialists Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831110725 PECOS PAC ID: 1254328818 Enrollment ID: O20040427000878 |
News Archive
Pairing chemotherapy nanodrugs with a nutritional supplement can lessen devastating side-effects while reducing the amount of the expensive drugs needed to treat cancer according to a study from Carnegie Mellon University and Taiwan's National Health Research Institutes.
The Northern Devon Healthcare Trust (NDHT) is using a speech recognition solution, from voice automation specialist Telephonetics VIP, to answer external calls at busy times.
Omeros Corporation today announced that patient enrollment has begun in the Company's second Phase 3 clinical trial evaluating OMS302 in intraocular lens replacement (ILR) surgery.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr James N Sikes, MD, 3688 Veterans Memorial Dr, Suite 200, Hattiesburg, MS 39401-8246 Ph: (601) 554-7400 | Dr James N Sikes, MD, 3688 Veterans Memorial Dr, Suite 200, Hattiesburg, MS 39401-8246 Ph: (601) 554-7400 |
News Archive
Pairing chemotherapy nanodrugs with a nutritional supplement can lessen devastating side-effects while reducing the amount of the expensive drugs needed to treat cancer according to a study from Carnegie Mellon University and Taiwan's National Health Research Institutes.
The Northern Devon Healthcare Trust (NDHT) is using a speech recognition solution, from voice automation specialist Telephonetics VIP, to answer external calls at busy times.
Omeros Corporation today announced that patient enrollment has begun in the Company's second Phase 3 clinical trial evaluating OMS302 in intraocular lens replacement (ILR) surgery.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
› Verified 6 days ago
Jeffrey A Burns, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5003 Hardy St Ste 401, Hattiesburg, MS 39402 Phone: 601-296-2100 Fax: 601-296-2106 | |
David W Bomboy, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5630 Fax: 601-268-5819 | |
Dr. Michael C Patterson, M.D., Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3688 Veterans Memorial Dr, Suite 200, Hattiesburg, MS 39401 Phone: 601-554-7400 Fax: 601-554-7488 | |
James S Williford, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5630 Fax: 601-268-5819 | |
Thomas Payne Royals, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 103 Tatum Rd, Hattiesburg, MS 39401 Phone: 601-268-5630 Fax: 601-268-5819 | |
Dr. James A Antinnes, M.D., Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3688 Veterans Memorial Dr, Suite 200, Hattiesburg, MS 39401 Phone: 601-554-7451 Fax: 601-554-7488 |